National Research Corp (NRC)
44.75
+0.14
(+0.31%)
USD |
NASDAQ |
Mar 29, 16:00
44.75
0.00 (0.00%)
After-Hours: 16:24
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.101B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 18.24% |
| Valuation | |
| PE Ratio | 35.24 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 7.397 |
| Price to Book Value | 15.28 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.12 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3079 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 53.71% |
News
Headline
Wire
Time (ET)
Yahoo
02/15 13:00
MT Newswires
02/14 17:08
Yahoo
02/14 17:00
Globe Newswire
01/30 15:34
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 08/02/2018 | 11:00 EST | Earnings Call | Q2 2018 | -- | -- | -- | |
| 08/01/2018 | -- | Results | Q2 2018 | 0.28 | 0.22 | 27.27% | |
| 05/03/2018 | 11:00 EST | Earnings Call | Q1 2018 | -- | -- | -- | |
| 05/02/2018 | -- | Results | Q1 2018 | 0.29 | 0.25 | 14.76% | |
| 02/15/2018 | 11:00 EST | Earnings Call | Q4 2017 | -- | -- | -- | |
| 02/14/2018 | -- | Results | Q4 2017 | 0.23 | 0.22 | 5.59% | |
| 11/02/2017 | 11:00 EST | Earnings Call | Q3 2017 | -- | -- | -- | |
| 11/02/2017 | -- | Results | Q3 2017 | 0.16 | 0.21 | -22.00% |
*Estimated Date/Time
Earnings
Profile
Edit
| National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States. |
| URL | https://www.nrchealth.com |
| Investor Relations URL | https://nrchealth.com/investor-relations/ |
| HQ State/Province | Nebraska |
| Sector | Healthcare |
| Industry | Health Information Services |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 01, 2018 |
| Next Ex-Dividend Date | Mar. 30, 2023 |
| Last Ex-Dividend Date | Dec. 29, 2022 |
Analyst Coverage
|
|
|
|
Low:--
High:--
|
|
| Price Target Std Dev |
|
| Price Target Upside (Daily) | Upgrade |
| Price Target Num Estimates | Upgrade |
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.84 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.971 |
| Yield to Sector | 0.6476 |
| Yield to Industry | 8.122 |
| Last Dividend Amt. | 0.12 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Dec. 29, 2022 |
| Yield (TTM) | 1.34% |
| Forward Yield | 1.61% |
| Payout Ratio | 65.92% |
| Cash Payout Ratio | 79.31% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 28, 2023.
Fundamentals
| Revenue (TTM) | 151.57M |
| Total Expenses (TTM) | 105.02M |
| Net Income (TTM) | 31.80M |
| Total Assets (Quarterly) | 130.46M |
| Total Liabilities (Quarterly) | 58.43M |
| Shareholders Equity (Quarterly) | 72.03M |
| Cash from Operations (TTM) | 36.26M |
| Cash from Investing (TTM) | -9.835M |
| Cash from Financing (TTM) | -55.58M |
Ratings
Profile
Edit
| National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States. |
| URL | https://www.nrchealth.com |
| Investor Relations URL | https://nrchealth.com/investor-relations/ |
| HQ State/Province | Nebraska |
| Sector | Healthcare |
| Industry | Health Information Services |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | Aug. 01, 2018 |
| Next Ex-Dividend Date | Mar. 30, 2023 |
| Last Ex-Dividend Date | Dec. 29, 2022 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
|
|
|
Low:--
High:--
|
|
| Price Target Std Dev |
|
| Price Target Upside (Daily) | Upgrade |
| Price Target Num Estimates | Upgrade |
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| NRC Tweets |